TrialClinical cancer research : an official journal of the American Association for Cancer Research2017

A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma.

Thomas C C Yau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.